Why Prescription Prices Keep Rising: A Plain-English Explainer

Prescription prices rise for a mix of interconnected reasons: manufacturers set and periodically raise list prices, competition is limited for many brand-name and some generic drugs, and the rebate-and-fee system used by pharmacy benefit managers (PBMs) adds layers of cost that don't always reach the patient at the counter. No single factor explains every price increase, and what you pay depends heavily on your insurance, pharmacy, and location.

If you've noticed your prescriptions costing more this year than last, you're not imagining it. Understanding the mechanics behind these increases won't make your bill smaller today, but it can help you know where to look for savings and what's actually within your control.

Manufacturers set list prices, and they don't need anyone's permission to raise them

In the U.S., unlike many other countries, drug manufacturers are largely free to set and change list prices as they see fit, since there is no single government body that negotiates or caps most prices before a drug goes to market. According to a federal analysis by ASPE (the Department of Health and Human Services' Office of the Assistant Secretary for Planning and Evaluation), more than 1,200 drug products had price increases between July 2021 and July 2022 that exceeded the general inflation rate of 8.5% for that period, with the average increase for those products at 31.6%. Some drugs saw increases of more than 500% in that window.

This matters because these list-price increases (technically called wholesale acquisition cost, or WAC) become the starting point for almost everything downstream: what pharmacies pay to stock the drug, what insurers negotiate rebates against, and often what an uninsured cash-paying patient sees at the register.

The rebate system creates a gap between list price and what gets paid

Most brand-name drug pricing in the U.S. runs through pharmacy benefit managers (PBMs), the companies that negotiate rebates and discounts between drug manufacturers and health plans. A 2024 FTC report on PBMs found that the three largest PBMs administer roughly 80% of all prescriptions filled in the United States and that these companies often steer patients toward their own affiliated pharmacies while reimbursing independent pharmacies less favorably. The rebates PBMs negotiate with manufacturers are usually confidential, so the list price you might read about in the news is rarely what actually changes hands between the manufacturer, the PBM, and the insurer. This opacity is part of why prescription pricing feels confusing: the sticker price, the negotiated price, and your copay can all be different numbers driven by different logic.

Compare prescription prices on BetterBuyRx if you want to see how the price for your specific medication varies across nearby pharmacies before assuming the list price is what you'll actually pay.

Limited competition keeps some prices elevated longer than others

Both brand-name and generic drug prices respond to competition, or the lack of it. The FDA's Generic Drug Facts page notes that a single generic competitor entering the market tends to lower prices by around 30%, and having five or more generic competitors is associated with price drops of nearly 85% compared to the brand price. This cuts both ways: when a generic drug has few manufacturers, perhaps because of a supply disruption or a market exit, prices for that generic can rise noticeably even though it's not a patented, brand-name product anymore.

Brand-name drugs face a different dynamic. Patent protections and market exclusivity periods can keep a drug free from generic competition for years, sometimes over a decade, during which the manufacturer can raise prices with limited competitive pressure.

Medicaid, Medicare, and state programs use their own pricing benchmarks

Government health programs don't simply pay list price. Medicaid uses a benchmark called the National Average Drug Acquisition Cost (NADAC), which reflects what pharmacies actually pay to acquire drugs, not the manufacturer's list price. According to KFF's overview of Medicaid prescription drug facts, states have flexibility in setting their actual acquisition cost methodology, which is part of why the same drug can be reimbursed differently from state to state, even within the same federal program.

Why your personal price doesn't always track the headlines

Because these are different numbers driven by different negotiations, a news headline about a drug's list price jumping 20% doesn't necessarily mean your copay changes at all, and it also doesn't mean it stays the same. It depends on your specific plan design.

What actually moves the needle on your own bill

Given how complicated the system is, a few practical levers remain within a patient's control. Comparing pharmacy prices before filling a new prescription can reveal meaningful differences, since pharmacies set their own cash prices and negotiate separately with PBMs. Asking your doctor or pharmacist whether a generic or a different drug in the same therapeutic class is appropriate is another option worth raising, though that's a clinical decision your prescriber should make, not something to decide on your own. If you take a maintenance medication, periodically checking whether a prescription discount card beats your copay is also worth the few minutes it takes.

Where inflation-linked policy fits in

The Inflation Reduction Act introduced a requirement that manufacturers pay rebates to Medicare when a Part D drug's price increase outpaces general inflation, a provision that began in October 2022, according to the ASPE report. This doesn't cap list prices outright, but it changes the financial incentives for manufacturers who raise prices faster than inflation on drugs covered under Medicare Part D. It's one example of how policy is starting to respond to the pattern of above-inflation increases documented in federal data, even though it doesn't touch every drug or every payer.

Talk to your pharmacist when a price surprises you

If a refill suddenly costs much more than it did last time, ask your pharmacist why. It could be a formulary change from your insurer, a shift in your plan year (deductibles reset annually), a manufacturer price increase, or a shortage affecting a generic. Pharmacists can often see the breakdown in their system and may be able to point you toward a lower-cost alternative or a prescription discount card that beats your current price. This is a cost conversation, not a medical one, so it's a reasonable thing to ask about even during a quick counter visit.

Search your medication on BetterBuyRx to see how its price compares across pharmacies near you, since even in a market with rising list prices, where you fill still matters. Prices vary by pharmacy, location, quantity, and eligibility, so there's no universal number that applies to everyone.

The bottom line for consumers

Rising prescription prices reflect structural features of the U.S. drug pricing system, not something any single company or decision is entirely responsible for. Manufacturers set list prices largely without restriction, PBMs negotiate confidential rebates that create a gap between list and net price, and competition (or the lack of it) shapes how quickly prices for any specific drug rise or fall. None of this is likely to change quickly, which is part of why comparison shopping and understanding your own plan's formulary remain practical steps for managing costs in the near term. Compare prescription prices near you as a routine part of managing any ongoing prescription, not just when a price hike catches you off guard.